Whereas Auto vs. Allo Cell Remedy Debate Continues, VCs Search for ‘Subsequent Shiny Factor’
One of many hottest debates in biotech in the present day includes cell remedy. Autologus cell therapies—therapies made by engineering...
VCs
At ViVE, How Did VCs Reply to Criticism of Their Business?
From left to proper: Lee Shapiro, Emily Melton, Richard Mulry, Ambar Bhattacharyya and Arundhati Parmar Digital well being funding within...
